The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Employment - Agendia
Leadership - Agendia
Stock and Other Ownership Interests - Agendia
Consulting or Advisory Role - Private Health
High-risk breast cancer genes at 8q22-24 and their role in over 5,000 patients evaluated with the 70-gene risk of recurrence assay.
 
Sami Diab
Stock and Other Ownership Interests - Bluebird Bio; Conatus; Immunogen; Immunomedics; Novocure; Viking Medical
Honoraria - Agendia; AstraZeneca; Genomic Health; Lilly; Myriad Genetics; Novartis; Pfizer
Consulting or Advisory Role - Agendia; Genentech; Genomic Health; Lilly; Myriad Genetics; Novartis; Pfizer; Puma Biotechnology
Speakers' Bureau - Agendia; Genentech; Genomic Health; Lilly; Novartis; Pfizer; Puma Biotechnology
Research Funding - Pfizer (Inst); Seagen (Inst)
Travel, Accommodations, Expenses - Genentech; Lilly; Novartis; Pfizer
 
Matei P. Socoteanu
Employment - Texas Oncology; Texas Oncology
Research Funding - AstraZeneca (Inst); AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Bristol-Myers Squibb (Inst); Genentech (Inst); Genentech (Inst); Lilly (Inst); Lilly (Inst); Merck (Inst); Merck (Inst); Seagen (Inst); Seagen (Inst)
 
Carlos A. Encarnacion
Employment - Texas Oncology
Leadership - Texas Oncology
Stock and Other Ownership Interests - Texas Oncology
Speakers' Bureau - Agendia
 
Cynthia R. C. Osborne
Consulting or Advisory Role - Myriad Pharmaceuticals; Seagen
Speakers' Bureau - Lilly; Novartis
 
Carolyn B. Hendricks
No Relationships to Disclose
 
Kristi McIntyre
No Relationships to Disclose
 
Vibha Taneja Thomas
Employment - Vizient
Stock and Other Ownership Interests - Texas Health Presbyterian Hospital Flower Mound
 
Rajith Bhaskaran
Employment - Agendia
Stock and Other Ownership Interests - Agendia
 
Lorenza Mittempergher
Employment - Agendia
Stock and Other Ownership Interests - Agendia
 
Andrea Menicucci
Employment - Agendia
Stock and Other Ownership Interests - Agendia
 
William Audeh
No Relationships to Disclose
 
Joyce O'Shaughnessy
Honoraria - Abbvie; Agendia; Amgen; AstraZeneca; Bristol-Myers Squibb; Celgene; Daiichi Sankyo; Eisai; Genentech; Genomic Health; GRAIL; HERON; Immunomedics; Ipsen; Jounce Therapeutics; Lilly; Merck; Myriad Pharmaceuticals; Novartis; Odonate Therapeutics; Pfizer; Puma Biotechnology; Roche; Samsung; Sanofi; Seagen; Syndax
Consulting or Advisory Role - Abbvie; Agendia; Amgen; AstraZeneca; Bristol-Myers Squibb; Celgene; Daiichi Sankyo; Eisai; Genentech; Genomic Health; GRAIL; HERON; Immunomedics; Ipsen; Jounce Therapeutics; Lilly; Merck; Myriad Pharmaceuticals; Novartis; Odonate Therapeutics; Pfizer; Puma Biotechnology; Roche; Samsung; Sanofi; Seagen; Syndax
Speakers' Bureau - AstraZeneca; Lilly; Novartis
Research Funding - Seagen (Inst)
Travel, Accommodations, Expenses - Abbvie; Agendia; Amgen; AstraZeneca; Celgene; Eisai; Genomic Health; GRAIL; Ipsen; Jounce Therapeutics; Lilly; Myriad Pharmaceuticals; Novartis; Pfizer; Puma Biotechnology; Roche; Sanofi; Seagen